Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00017329
Status:
COMPLETED
Last Update Posted:
2009-12-15
First Post:
2001-06-06
Brief Title:
PS-341 in Treating Patients With Metastatic Kidney Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
Phase II Trial of PS341 NSC 681239 in Patients With Advanced Renal Cell Carcinoma
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die
PURPOSE Phase II trial to study the effectiveness of PS-341 in treating patients who have metastatic kidney cancer
PURPOSE Phase II trial to study the effectiveness of PS-341 in treating patients who have metastatic kidney cancer
Detailed Description:
OBJECTIVES
Determine the efficacy of PS-341 in patients with metastatic renal cell carcinoma
Determine the safety of this drug in these patients
OUTLINE This is an open-label study
Patients receive PS-341 IV over 3-5 seconds twice weekly for 2 weeks Treatment repeats every 3 weeks in the absence of disease progression or unacceptable toxicity
Patients are followed at 2 weeks
PROJECTED ACCRUAL A total of 12-37 patients will be accrued for this study within 6-19 months
Determine the efficacy of PS-341 in patients with metastatic renal cell carcinoma
Determine the safety of this drug in these patients
OUTLINE This is an open-label study
Patients receive PS-341 IV over 3-5 seconds twice weekly for 2 weeks Treatment repeats every 3 weeks in the absence of disease progression or unacceptable toxicity
Patients are followed at 2 weeks
PROJECTED ACCRUAL A total of 12-37 patients will be accrued for this study within 6-19 months
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-3031 | None | None | None |
| MSKCC-01032 | None | None | None |